Summary:
A randomized, double-blind, placebo-controlled trial of adjunctive BHV-4157 in Obsessive Compulsive Disorder
Qualified Participants Must:
Male and female outpatient subjects between the ages of 18 - 65
Must have a diagnosis of obsessive-compulsive disorder (OCD)
Qualified Participants May Receive:
Compensation for time and travel